116 related articles for article (PubMed ID: 22078205)
1. Reciprocal coordination of a combination oral contraceptive containing desogestrel+ethinyl estradiol on the expression of LOX-1 and LDLR in placental trophoblast cells.
Pandey H; Arjuman A; Roy KK; Chandra NC
Contraception; 2011 Dec; 84(6):e43-9. PubMed ID: 22078205
[TBL] [Abstract][Full Text] [Related]
2. Effect of a combination oral contraceptive (desogestrel+ethinyl estradiol) on the expression of low-density lipoprotein receptor and its transcription factor (SREBP2) in placental trophoblast cells.
Arjuman A; Pandey H; Chandra NC
Contraception; 2011 Aug; 84(2):160-8. PubMed ID: 21757058
[TBL] [Abstract][Full Text] [Related]
3. Study of low-density lipoprotein receptor regulation by oral (steroid) contraceptives: desogestrel, levonorgestrel and ethinyl estradiol in JEG-3 cell line and placental tissue.
Ramakrishnan G; Rana A; Das C; Chandra NC
Contraception; 2007 Oct; 76(4):297-305. PubMed ID: 17900441
[TBL] [Abstract][Full Text] [Related]
4. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
Kemmeren JM; Algra A; Meijers JC; Bouma BN; Grobbee DE
Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
[TBL] [Abstract][Full Text] [Related]
5. [The effect of contraceptive with 20 ug ethinylestradiol and 150 ug desogestrel on some acute phase proteins].
Uchikova E; Batashki I; Milchev N; Mateva N; Markova D; Gŭrova A
Akush Ginekol (Sofiia); 2006; 45(2):39-43. PubMed ID: 16637303
[TBL] [Abstract][Full Text] [Related]
6. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
[TBL] [Abstract][Full Text] [Related]
7. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
Middeldorp S; Meijers JC; van den Ende AE; van Enk A; Bouma BN; Tans G; Rosing J; Prins MH; Büller HR
Thromb Haemost; 2000 Jul; 84(1):4-8. PubMed ID: 10928461
[TBL] [Abstract][Full Text] [Related]
8. Bleeding pattern with drospirenone 3 mg+ethinyl estradiol 20 mcg 24/4 combined oral contraceptive compared with desogestrel 150 mcg+ethinyl estradiol 20 mcg 21/7 combined oral contraceptive.
Anttila L; Kunz M; Marr J
Contraception; 2009 Nov; 80(5):445-51. PubMed ID: 19835718
[TBL] [Abstract][Full Text] [Related]
9. Clinical review of a monophasic oral contraceptive containing desogestrel and ethinyl estradiol.
Stone S
Int J Fertil Menopausal Stud; 1993; 38 Suppl 3():117-21. PubMed ID: 8260969
[TBL] [Abstract][Full Text] [Related]
10. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
Tans G; Curvers J; Middeldorp S; Thomassen MC; Meijers JC; Prins MH; Bouma BN; Büller HR; Rosing J
Thromb Haemost; 2000 Jul; 84(1):15-21. PubMed ID: 10928463
[TBL] [Abstract][Full Text] [Related]
11. [A combiphasic oral contraceptive containing ethinylestradiol and desogestrel].
Poulsen HK
Ugeskr Laeger; 1995 Aug; 157(32):4473-5. PubMed ID: 7483033
[No Abstract] [Full Text] [Related]
12. Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome.
Kriplani A; Periyasamy AJ; Agarwal N; Kulshrestha V; Kumar A; Ammini AC
Contraception; 2010 Aug; 82(2):139-46. PubMed ID: 20654754
[TBL] [Abstract][Full Text] [Related]
13. Extended regimens of the contraceptive vaginal ring versus hormonal oral contraceptives: effects on lipid metabolism.
Guazzelli CA; Barreiros FA; Barbosa R; Torloni MR; Barbieri M
Contraception; 2012 Apr; 85(4):389-93. PubMed ID: 22067754
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of hormonal suppression with two contraceptive regimens using ethinyl estradiol and desogestrel.
Gassen DT; Herter LD; Chagas JK; Schmid H
Arch Gynecol Obstet; 2013 Feb; 287(2):289-94. PubMed ID: 22976131
[TBL] [Abstract][Full Text] [Related]
15. [What does the micropill bring?].
Mall-Haefeli M
Ther Umsch; 1986 May; 43(5):365-71. PubMed ID: 2941889
[No Abstract] [Full Text] [Related]
16. The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters.
Winkler UH; Sudik R
Contraception; 2009 Jan; 79(1):15-23. PubMed ID: 19041436
[TBL] [Abstract][Full Text] [Related]
17. Clinical review of a monophasic oral contraceptive containing desogestrel and ethinyl estradiol.
Stone S
Int J Fertil; 1992; 37(5):286-9. PubMed ID: 1358840
[No Abstract] [Full Text] [Related]
18. [Effect of the monophase oral contraceptive combination with 20 ug ethinyl estradiol/150 ug desogestrel on haemostasis].
Uchikova E; Milchev N; Terzhumanov R; Markova D
Akush Ginekol (Sofiia); 2004; 43(4):29-32. PubMed ID: 15318540
[TBL] [Abstract][Full Text] [Related]
19. Clinical experience of a combined oral contraceptive with very low dose ethinyl estradiol.
Akerlund M
Acta Obstet Gynecol Scand Suppl; 1997; 164():63-5. PubMed ID: 9225641
[TBL] [Abstract][Full Text] [Related]
20. [Combined hormonal contraception in cycles artificially extended].
Bustillos-Alamilla E; Zepeda-Zaragoza J; Hernández-Ruiz MA; Briones-Landa CH
Ginecol Obstet Mex; 2010 Jan; 78(1):37-45. PubMed ID: 20931801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
